Evidence presented in vitro and in vivo suggested that WA inhibited HCC cell proliferation and tumorigenesis through miR-22-repressed CCNA2, which was at least partially through FXR modulation. This evidence concerns the gene CCNA2 and hepatocellular carcinoma.